Table 4.
Intervention | Target population |
Unit cost of intervention (US$) |
Total cost (US$) |
$ per DALY | Adherence | DALYS averted |
Ratio of benefits to costs (cost-effectiveness) |
---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
1 | 2 | 3 | 4 | 5 | 6 | 7 | |
HIV | |||||||
Testing | 1,700,000 | 17 | 28,900,000 | 38.27 | 0.39 | 294,512.67 | 0.0102 |
ART first line treatment | 500,000 | 511 | 255,500,000 | 451.50 | 0.80 | 452,713.18 | 0.0018 |
TB | |||||||
DOTS treatment | 20,000 | 755 | 15,100,000 | 132.96 | 0.95 | 107,889.59 | 0.0071 |
Diagnosis | 140,000 | 9.98 | 1,397,200 | 126.35 | 0.34 | 3759.78 | 0.0027 |
MDR-TB treatment | 100 | 7595 | 759,500 | 521.96 | 0.80 | 1164.07 | 0.0015 |
Malaria | |||||||
Treatment with ACTs | 5,000,000 | 2.03 | 10,150,000 | 13.91 | 0.60 | 437,814.52 | 0.0431 |
Intermittent preventive treatment in pregnancy (IPTp) | 945,000 | 0.30 | 283,500 | 25.68 | 0.40 | 4415.89 | 0.0156 |